| Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics MM Rawas-Qalaji, F Estelle, R Simons, KJ Simons AAPS PharmSciTech 7, E72-E78, 2006 | 114 | 2006 |
| Advances in ocular drug delivery M Rawas-Qalaji, CA Williams Current eye research 37 (5), 345-356, 2012 | 104 | 2012 |
| Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis MM Rawas-Qalaji, FER Simons, KJ Simons Journal of allergy and clinical immunology 117 (2), 398-403, 2006 | 102 | 2006 |
| Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy Z Hussain, MA Rahim, N Jan, H Shah, M Rawas-Qalaji, S Khan, M Sohail, ... Journal of Controlled Release 335, 130-157, 2021 | 93 | 2021 |
| An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine O Rachid, FER Simons, M Rawas-Qalaji, KJ Simons Aaps Pharmscitech 11, 550-557, 2010 | 88 | 2010 |
| Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis M Rawas-Qalaji, FER Simons, D Collins, KJ Simons Annals of Allergy, Asthma & Immunology 102 (6), 500-503, 2009 | 64 | 2009 |
| Polymeric nanoparticles as tunable nanocarriers for targeted delivery of drugs to skin tissues for treatment of topical skin diseases EA Madawi, AR Al Jayoush, M Rawas-Qalaji, HE Thu, S Khan, M Sohail, ... Pharmaceutics 15 (2), 657, 2023 | 58 | 2023 |
| Treating organophosphates poisoning: management challenges and potential solutions M Alozi, M Rawas-Qalaji Critical reviews in toxicology 50 (9), 764-779, 2020 | 54 | 2020 |
| Dissolution Testing of Sublingual Tablets: A Novel In Vitro Method O Rachid, M Rawas-Qalaji, FER Simons, KJ Simons AAPS PharmSciTech 12, 544-552, 2011 | 49 | 2011 |
| Fast-disintegrating epinephrine tablets for buccal or sublingual administration M Rawas-Qalaji, K Simons, X Gu, E Simons US Patent App. 11/672,503, 2007 | 42 | 2007 |
| Recent progress in micro and nano-encapsulation techniques for environmental applications: A review SS Ayyaril, A Shanableh, S Bhattacharjee, M Rawas-Qalaji, R Cagliani, ... Results in Engineering 18, 101094, 2023 | 40 | 2023 |
| Recent developments and advanced strategies for promoting burn wound healing Z Hussain, HE Thu, M Rawas-Qalaji, M Naseem, S Khan, M Sohail Journal of Drug Delivery Science and Technology 68, 103092, 2022 | 37 | 2022 |
| Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics MM Rawas-Qalaji, FER Simons, KJ Simons Drug development and industrial pharmacy 33 (5), 523-530, 2007 | 36 | 2007 |
| Semiconductor integrated circuit device and a method of manufacturing the same Y Taniguchi, S Shukuri, K Kuroda, S Ikeda, T Hashimoto US Patent App. 10/251,849, 2003 | 36 | 2003 |
| Epinephrine doses contained in outdated epinephrine auto-injectors collected in a Florida allergy practice O Rachid, FER Simons, MB Wein, M Rawas-Qalaji, KJ Simons Annals of Allergy, Asthma & Immunology 114 (4), 354-356. e1, 2015 | 35 | 2015 |
| Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development O Rachid, M Rawas-Qalaji, FER Simons, KJ Simons European journal of pharmaceutics and biopharmaceutics 82 (3), 598-604, 2012 | 34 | 2012 |
| Fast-disintegrating epinephrine tablets for buccal or sublingual administration M Rawas-Qalaji, K Simons, X Gu, E Simons US Patent App. 11/530,360, 2007 | 34 | 2007 |
| Essential Oil-Based Design and Development of Novel Anti-Candida Azoles Formulation R Hamdy, B Fayed, AM Hamoda, M Rawas-Qalaji, M Haider, ... Molecules 25 (6), 1463, 2020 | 32 | 2020 |
| Epinephrine in anaphylaxis: Preclinical study of pharmacokinetics after sublingual administration of taste-masked tablets for potential pediatric use O Rachid, M Rawas-Qalaji, KJ Simons Pharmaceutics 10 (1), 24, 2018 | 31 | 2018 |
| Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same … MM Rawas‐Qalaji, FER Simons, KJ Simons Biopharmaceutics & drug disposition 27 (9), 427-435, 2006 | 31 | 2006 |
